Prodia Diagnostic Line is trading at IDR 139.00, up 5.30%, with no clearly established company-specific catalyst identified for the October 22 move.
- Indonesian equities faced changing sentiment around MSCI-related concerns and exchange measures, but available coverage does not establish these factors directly explain the gain.
- Previous-session company-specific price coverage reported a rise but did not identify a catalyst for October 22.